Log In or Register to Join The Conversation!

SMA News & Perspectives – Weekly Recap (Dec 2 – Dec 6)

This topic is empty.

  • Author
    Posts
    • #21614

      SMA News Today forums moderators and contributors have been joining forces to create exclusive audio content for the SMA community. Here are the podcast episodes from December 2 to December 6.

      December 2

      We discuss how a study of MRI scans of facial nerves, can help diagnose spinal and bulbar muscular atrophy & Along with being a friend, pets teach responsibility. As long as they get TLC, they don’t seem to care about disabilities. If you or your child has a pet on their Christmas wish-list, it might be worth considering.

      ***

       

      December 4

      Forums Director Kevin Schaefer reflects on the past decade in his latest
      column. Although the forum moderators took a short break from posting over the Thanksgiving holiday, there are several great conversations going on: Risdiplam getting fast tracked for approval raises questions in the community and Giving Tuesday is a topic of interest as well along with the subject of social media.

      ***

       

      December 6

      We discuss a study that suggests how MRI fiber tracking may be a potential biomarker of SMA course and response to therapy. Forums Director Kevin Schaefer shares his thoughts on the experimental therapy risdiplam. If FDA-approved, this drug would be the first oral treatment for SMA.

      Are you interested in learning more about the latest treatment for spinal muscular atrophy? Visit TreatSMA.com to see how this treatment works, hear about family stories, and learn about the steps to starting treatment. Visit TreatSMA.com.

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2020 All rights reserved.